Birchview Capital, LP - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 279 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
Birchview Capital, LP ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,009,936
-16.1%
240,400
-3.6%
4.26%
-4.8%
Q2 2023$5,973,130
+127150.3%
249,4000.0%4.48%
+21.8%
Q1 2023$4,694
+18.2%
249,4000.0%3.68%
+31.1%
Q4 2022$3,970
-99.9%
249,4000.0%2.80%
-2.4%
Q3 2022$4,080,000
+16.1%
249,4000.0%2.87%
+12.4%
Q2 2022$3,514,000
-27.2%
249,400
+25.1%
2.56%
-26.5%
Q1 2022$4,829,000
+3.8%
199,4000.0%3.48%
+15.9%
Q4 2021$4,654,000
+40.5%
199,4000.0%3.00%
+33.1%
Q3 2021$3,312,000
-31.9%
199,4000.0%2.25%
-22.5%
Q2 2021$4,863,000
+6.5%
199,400
+12.7%
2.91%
+7.3%
Q1 2021$4,567,000
-16.2%
177,000
+73.5%
2.71%
-13.7%
Q4 2020$5,453,000
-35.2%
102,000
-50.0%
3.14%
+11.8%
Q3 2020$8,416,000
+86.7%
204,000
+119.4%
2.81%
+3.2%
Q2 2020$4,508,000
+16.0%
93,000
+1.1%
2.72%
-21.0%
Q1 2020$3,887,000
+548.9%
92,000
+557.1%
3.45%
+692.6%
Q4 2019$599,000
+18.8%
14,0000.0%0.44%
+29.5%
Q3 2019$504,000
+88.8%
14,000
+40.0%
0.34%
+107.4%
Q2 2019$267,00010,0000.16%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Baker Brothers Advisors 27,228,338$611,821,0005.19%
First Washington CORP 176,950$3,976,0002.06%
SECTORAL ASSET MANAGEMENT INC 783,424$17,604,0001.93%
HARVEY CAPITAL MANAGEMENT INC 219,042$4,921,0001.84%
Ghost Tree Capital, LLC 400,000$8,988,0001.82%
Opus Point Partners Management, LLC 36,733$825,0001.62%
Palo Alto Investors LP 1,650,780$37,093,0001.59%
EMORY UNIVERSITY 84,714$1,904,0001.36%
GARRISON BRADFORD & ASSOCIATES INC 69,000$1,550,0001.32%
HealthCor Management, L.P. 1,378,000$30,964,0001.05%
View complete list of ACADIA PHARMACEUTICALS INC shareholders